Skip to contentS
SkinHealth Systems Inc.
S
SKINSkinHealth Systems Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$83.50M$83.50Mderived−13.8% vs Q4 2023 Net Income-$10.33M-$10.33MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SkinHealth Systems Inc. · CIK 1818093 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$52,346,000+14.6% Operating Incomederived-$7,157,000N/M Operating Cash Flowderived$16,472,000N/M Free Cash Flowderived$16,398,000N/M Margins · derivedGross margin62.7%+15.5 pt vs Q4 2023
Operating margin-8.6%+10.4 pt vs Q4 2023
Net margin-12.4%−2.7 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 12, 2025 · 71 d after period end